AKBA Jul 2024 1.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:48AM EDT. Market open.
| Previous close | 0.0500 |
| Open | 0.1000 |
| Bid | 0.0500 |
| Ask | 0.1500 |
| Strike | 1.50 |
| Expiry date | 2024-07-19 |
| Day's range | 0.1000 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 737 |
PR NewswireAkebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the 2nd Annual HCW Bioconnect Investor Conference on Monday, May 20th, 2024 at 3:00 p.m. ET.
Simply Wall St.Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
The analysts covering Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) delivered a dose of negativity to shareholders today...
GuruFocus.comAkebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Insights into Akebia Therapeutics' Performance and Strategic Developments
© 2024 Yahoo. All rights reserved.